These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Adenylate cyclase system of differentiating erythroid cells.
    Author: Setchenska MS.
    Journal: Acta Physiol Pharmacol Bulg; 1990; 16(2):3-10. PubMed ID: 2281799.
    Abstract:
    The review provides a survey of current knowledge about the changes in hormone-sensitive adenylate cyclase complex of erythroid cells. The basal enzyme activity decreases continuously during differentiation and maturation. Guanine nucleotides (GTP and GMP-P (NH)P) increase the adenylate cyclase activity of both early and late rabbit bone marrow erythroblasts. The stimulating effect of the beta 2-adrenergic drugs such as L-isoprenaline is limited to the immature cells. L-noradrenaline, a beta 1-agonist is inactive. The lack of response of non-dividing rabbit erythroblasts to beta-adrenergic stimuli is not due to loss of beta-receptors during differentiation, but to a decrease in the effectiveness of the coupling between the components of the system: receptor-guanine nucleotide regulatory protein-catalytic subunit. Prostaglandins E1 and E2 consistently enhance adenylate cyclase activity of erythroblasts on different stages of development. Erythropoietin (0.2 U/ml) causes a transient increase in the activity of adenylate cyclase, which is maximal by 20 min incubation of the cells in the presence of the hormone and disappears within 4 hours. The magnitude of the response to erythropoietin depends on the stage of erythroid cell development and is inverse related to the extent of previous hormonal stimulation of the cell.
    [Abstract] [Full Text] [Related] [New Search]